NYSEMKT: NSRXNasus Pharma Ltd Stock Ownership - Who owns Nasus Pharma?
Insider buying vs selling
Have Nasus Pharma Ltd insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Dan Benjamin Teleman | Chief Executive Officer | 2026-06-17 | 6,550 | $3.10 | $20.31kBuy |
| Dan Benjamin Teleman | Chief Executive Officer | 2026-04-22 | 2,900 | $3.76 | $10.90kBuy |
| Dan Benjamin Teleman | Chief Executive Officer | 2026-03-31 | 15,000 | $2.04 | $30.60kBuy |
NSRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NSRX insiders and whales buy or sell their stock.
NSRX Shareholders
What type of owners hold Nasus Pharma Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Udi Gilboa | 21.35% | 1,924,476 | $6.74M | Insider |
| Dalia Megiddo | 21.01% | 1,894,068 | $6.63M | Insider |
| Ronnie Hershman | 14.85% | 1,338,463 | $4.68M | Insider |
| Balyasny Asset Management LP | 9.97% | 898,473 | $3.14M | Institution |
| Cable Car Capital LP | 6.68% | 601,998 | $2.11M | Institution |
| Velan Capital Investment Management LP | 3.99% | 359,390 | $1.26M | Institution |
| Dan Benjamin Teleman | 1.81% | 163,541 | $572.39k | Insider |
| Hudson Bay Capital Management LP | 1.49% | 134,771 | $471.70k | Institution |
| Bleichroeder LP | 1.00% | 89,848 | $314.47k | Institution |
| Empery Asset Management LP | 0.51% | 45,803 | $160.31k | Institution |
NSRX vs General Drug Manufacturer Stocks
Nasus Pharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.